论文部分内容阅读
目的:评价氯雷他定联合丙卡特罗治疗咳嗽变异性哮喘的疗效。方法:44例患者随机分为治疗组和对照组,治疗组用氯雷他定﹢盐酸丙卡特罗治疗,对照组用布地奈德治疗。结果:治疗组总有效率97%,对照组总有效率100%,两组临床疗效比较差异无显著性(P>0.05)。结论:氯雷他定﹢盐酸丙卡特罗治疗咳嗽变异性哮喘效果良好,值得临床推广应用。
Objective: To evaluate the efficacy of loratadine combined with procaterol in the treatment of cough variant asthma. Methods: Forty-four patients were randomly divided into treatment group and control group. The treatment group was treated with loratadine and procaterol hydrochloride, while the control group was treated with budesonide. Results: The total effective rate was 97% in the treatment group and 100% in the control group. There was no significant difference in clinical curative effect between the two groups (P> 0.05). Conclusion: Loratadine and procaterol hydrochloride are effective in treating cough variant asthma, which is worthy of clinical application.